Jeremy P. Mallari, Ph.D.
Affiliations: | 2008 | Chemistry and Chemical Biology | University of California, San Francisco, San Francisco, CA |
Area:
Pharmaceutical ChemistryGoogle:
"Jeremy Mallari"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| R. Kip Guy | grad student | 2004-2008 | UCSF | |
| (Development of potent and selective trypanocides by targeting of the trypanosomal protease Tbcat B.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Eagon S, Howland M, Heying M, et al. (2021) Identification of Plasmodium falciparum falcilysin inhibitors by a virtual screen. Bioorganic & Medicinal Chemistry Letters. 52: 128394 |
| Kahlon G, Lira R, Masvlov N, et al. (2021) Corrigendum to "Structure guided development of potent piperazine-derived hydroxamic acid inhibitors targeting falcilysin" [Bioorg. Med. Chem. Lett. 32 (2021) 127683]. Bioorganic & Medicinal Chemistry Letters. 37: 127836 |
| Kahlon G, Lira R, Masvlov N, et al. (2020) Structure Guided Development of Potent Piperazine-Derived Hydroxamic Acid Inhibitors Targeting Falcilysin. Bioorganic & Medicinal Chemistry Letters. 127683 |
| Chance JP, Fejzic H, Hernandez O, et al. (2018) Development of piperazine-based hydroxamic acid inhibitors against falcilysin, an essential malarial protease. Bioorganic & Medicinal Chemistry Letters |
| Istvan ES, Mallari JP, Corey VC, et al. (2017) Esterase mutation is a mechanism of resistance to antimalarial compounds. Nature Communications. 8: 14240 |
| Zhang F, Tagen M, Throm S, et al. (2011) Whole-body physiologically based pharmacokinetic model for nutlin-3a in mice after intravenous and oral administration. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 15-21 |
| Mallari JP, Zhu F, Lemoff A, et al. (2010) Optimization of purine-nitrile TbcatB inhibitors for use in vivo and evaluation of efficacy in murine models. Bioorganic & Medicinal Chemistry. 18: 8302-9 |
| Mallari JP, Shelat AA, Kosinski A, et al. (2009) Structure-guided development of selective TbcatB inhibitors. Journal of Medicinal Chemistry. 52: 6489-93 |
| Mallari JP, Guiguemde WA, Guy RK. (2009) Antimalarial activity of thiosemicarbazones and purine derived nitriles. Bioorganic & Medicinal Chemistry Letters. 19: 3546-9 |
| Mallari JP, Shelat A, Kosinski A, et al. (2008) Discovery of trypanocidal thiosemicarbazone inhibitors of rhodesain and TbcatB. Bioorganic & Medicinal Chemistry Letters. 18: 2883-5 |